RXRX
Recursion Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.79B
P/E Ratio
—
EPS
$-1.44
Beta
1.01
52W High
$7.18
52W Low
$2.80
50-Day MA
$3.60
200-Day MA
$4.70
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that decodes biology by integrating technological innovations in biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company is headquartered in Salt Lake City, Utah.
Fundamentals
| Revenue (TTM) | $74.68M |
| Gross Profit (TTM) | $-471.54M |
| EBITDA | $-564.43M |
| Operating Margin | -328.80% |
| Return on Equity | -59.50% |
| Return on Assets | -27.70% |
| Revenue/Share (TTM) | $0.17 |
| Book Value | $2.14 |
| Price-to-Book | 1.45 |
| Price-to-Sales (TTM) | 23.98 |
| EV/Revenue | 13.16 |
| EV/EBITDA | -5.31 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 682.00% |
| Shares Outstanding | $521.95M |
| Float | $510.32M |
| % Insiders | 2.86% |
| % Institutions | 64.55% |
Analyst Ratings
Consensus ($6.71 target)
2
Strong Buy1
Buy5
HoldData last updated: 4/9/2026